Medifast, Inc. (MED) Tops Q1 EPS by 9c; Issues Mixed Outlook
Medifast, Inc. (NYSE: MED) reported Q1 EPS of $0.43, $0.09 better than the analyst estimate of $0.34. Revenue for the ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
